[CAS NO. 936623-90-4]  Sacubitril/valsartan (LCZ696)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [936623-90-4]

Store
Catalog
SLK-S7678
Brand
Selleck
CAS
936623-90-4

DESCRIPTION [936623-90-4]

Overview

MDL-
Molecular Weight915.98
Molecular FormulaC24H29N5O3.C24H29NO5.5/2H2O.3Na
SMILESC(N([C@@H]([C@H](C)C)C(O)=O)C(CCCC)=O)C1=CC=C(C2=C(C=CC=C2)C=3NN=NN3)C=C1.C([C@H](C[C@H](C(OCC)=O)C)NC(CCC(O)=O)=O)C1=CC=C(C=C1)C2=CC=CC=C2.[NaH].O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.0917 mL5.4586 mL10.9173 mL
5 mM0.2183 mL1.0917 mL2.1835 mL
10 mM0.1092 mL0.5459 mL1.0917 mL
50 mM0.0218 mL0.1092 mL0.2183 mL

Description

Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting for hypertension and heart failure. Phase 3.

Targets

RAAS [1]

In vivo

In double-transgenic rats overexpressing human renin and angiotensinogen and plasma atrial natriuretic peptide immunoreactivity, LCZ696 (60 mg/kg p.o.) induces a dose-dependent and long-lasting reduction in mean arterial pressure (MAP), and stimulates a rapid and dose-dependent augmentation of plasma ANP immunoreactivity. In rat myocardial infarction (MI) model, LCZ696 (68 mg/kg p.o.) attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.


Synonyms

L-Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, compd. with α-ethyl (αRS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl[1,1′-biphenyl]-4-pentanoate, sodium salt, hydrate (2:2:6:5)
LCZ 696
Entresto
Sacubitril-valsartan mixt.
Sacubitril-valsartan
Neparvis